Announcement of the 15 medicines chosen for the second round of negotiations is one of the Biden administration’s final ...

The Centers for Medicare & Medicaid Services (CMS) said Friday that it had selected another 15 drugs for its second round of ...

Announcing the 15 medicines chosen for the second round of negotiations is one of the Biden administration’s final health ...

Gladis Angarita, 62, fled her village in northeast Colombia in terror last Friday, among thousands escaping a fresh guerrilla ...

AstraZeneca’s respiratory and immunology portfolio is driving significant growth, with R&I assets forecasted to account for ...

FDA Commissioner Robert Califf is closing the book on his second stint leading the agency that regulates products accounting ...

The upcoming release of Phase III Fasenra data in COPD in 2025 is expected to solidify AstraZeneca’s position in the market.

Data collected from children with asthma and other respiratory conditions. Outcome measures Children/carers attending hospital were asked how they identify an empty salbutamol inhaler ... will be able ...

Medicare will soon start paying lower prices for Novo Nordisk’s weight- loss drug Wegovy and its Type 2 diabetes treatment ...

MRI of inhaled perfluoropropane can assess regional lung ventilation and monitor improvements in response to medication ...

A Reuters analysis shows that Berkshire coal plants emit more nitrogen oxide gases than any other coal-fired fleet in the ...

A study led by Aston University's Dr Gemma Heath and Dr Prasad Nagakumar from Birmingham Children's Hospital, has shown that treatment and diagnosis for preschool wheeze needs more effective ...